|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,807.75 DKK | +0.79% |
|
-1.64% | -10.98% |
| 04/03 | SHB Sees Multiple Potential Share Price Triggers for Genmab, Raises Target Price | FW |
| 03/03 | Handelsbanken Raises Genmab Price Target to 2,220 Danish Kroner (from 2,200), Reiterates Buy - BN | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GENMAB A/S | Bio Therapeutic Drugs | +0.61% | -1.64% | -10.98% | +9.07% | -5.10% | 1.72TCr |  |  |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- GMAB Stock
- Charts Genmab A/S
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition